Using human studies and mouse malaria infection models, our results revealed a novel and previously unexplored role for CTLA‐4, showing that low parasitemia levels in clinically silent persistent infections are also capable of activating this suppressive pathway, thereby preventing full control of parasite replication. This evidence concerns the gene CTLA4 and parasitic infectious disease.